These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8136318)

  • 41. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.
    Teulings HE; Willemsen KJ; Glykofridis I; Krebbers G; Komen L; Kroon MW; Kemp EH; Wolkerstorfer A; van der Veen JP; Luiten RM; Tjin EP
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1086-96. PubMed ID: 25043574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
    Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
    J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular analysis of vitiligo lesions reveals sporadic melanocyte survival.
    Gottschalk GM; Kidson SH
    Int J Dermatol; 2007 Mar; 46(3):268-72. PubMed ID: 17343582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smyth chicken melanocyte autoantibodies: cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum.
    Searle EA; Austin LM; Boissy YL; Zhao H; Nordlund JJ; Boissy RE
    Pigment Cell Res; 1993 Jun; 6(3):145-57. PubMed ID: 8234200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo.
    Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH
    J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo.
    Maresca V; Roccella M; Roccella F; Camera E; Del Porto G; Passi S; Grammatico P; Picardo M
    J Invest Dermatol; 1997 Sep; 109(3):310-3. PubMed ID: 9284096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitiligo and antibodies to melanocytes.
    Bystryn JC; Pfeffer S
    Prog Clin Biol Res; 1988; 256():195-206. PubMed ID: 3285350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
    Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
    J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library.
    Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    J Invest Dermatol; 2010 Jan; 130(1):230-40. PubMed ID: 19587696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intelligent bioengineering in vitiligo treatment: transdermal protein transduction of melanocyte-lineage-specific genes.
    Mou Y; Jiang X; Du Y; Xue L
    Med Hypotheses; 2012 Dec; 79(6):786-9. PubMed ID: 22999738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
    Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
    al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
    J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishing melanocyte cultures in a serum-free system for transplantation in vitiligo patients.
    Czajkowski R; Placek W; Drewa T; Olszewska-Słonina D; Sir J; Kowaliszyn B; Weiss M
    Med Sci Monit; 2006 Feb; 12(2):CR63-9. PubMed ID: 16449949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.